Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| MedTeq | INDUSTRY |
| Healthy Brains for Healthy Lives | UNKNOWN |
| Mitacs | INDUSTRY |
| PhysioBiometrics Inc. |
Not provided
Not provided
Not provided
Not provided
This project aims to improve how people with Parkinson's Disease (PD) walk. The global aim is to identify obstacles and solutions for people with PD for adopting technology to track and improve their gait to make them better and safer walkers. To meet this aim members of Parkinson Quebec will be surveyed about their technology readiness, physical, cognitive, and psychological health, and rehabilitation access. The survey should not take more than 20 minutes to complete on the web. Subsequently, a random sample of 100 survey participants will be offered a wearable device, the Heel2ToeTM sensor, designed to improve gait quality. This device emits a beep when a proper step is taken. This external cue reinforces the adoption of an adequate gait. In addition to the device, participants will be offered 5 sessions of telemonitoring to help them use the device optimally. Monitoring of use and outcomes will be over 3 months and the sensor is theirs to keep.
The global aim of this research program is to identify technical, attitudinal, and motivational obstacles and solutions for people with PD for adopting technology to improve gait and to quantify changes in gait biomechanics that will make participants better and safer walkers, ultimately improving physical function, physical activity, motivation, and quality of life.
Specific objective: Among members of the PQ who meet the criteria for technology readiness and have sufficient walking capacity to use the Heel2ToeTM sensor at home, the objectives are to estimate the extent to which they: (1) require support from the technology and rehabilitation team to optimize use; (2) use the sensor; (3) and change gait pattern, walking behaviours, motivation and functional and quality of life indicators over a period of 3 months.
Design: An individualized, blocked, stepped-wedge design will be used, a design favoured for implementation science questions 63,64 and applicable here as the team does not have the resources to implement the technology to all participants all at once. Parkinson Quebec has provided funds to provide sensors for 100 people. Variable size clusters of people will be formed and randomized to receive the Heel2Toe sensor, training, and remote supervised use, at intervals of 3 weeks. The cluster size will be randomly determined ranging from 4 to 10. As everyone selected for the implementation have already filled out the survey, there is a common data set at project entry. This assessment will be repeated prior to being entered into the Heel2Toe phase and then 3 months later.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Immediate assignment | Experimental | Within this block, half are assigned to receive the sensor right away. |
|
| Delayed assignment | Active Comparator | Within this block, half are assigned to receive the sensor after a delay of 3 to 4 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Heel2Toe[TM] sensor | Device | Heel2Toe is a new generation of wearables that provides real-time auditory feedback when the person takes a good step, one in which the step is initiated with a strong heel strike. |
| Measure | Description | Time Frame |
|---|---|---|
| Angular velocity of ankle at heel strike averaged over a walk of a least 50 steps | degrees per second | Change from baseline to 3 months, 6 months, 1 year |
| Angular velocity of ankle during push-off averaged over a walk of a least 50 steps | degrees per second | Change from baseline to 3 months, 6 months, 1 year |
| Angular velocity of ankle during foot swing averaged over a walk of a least 50 steps | degrees per second | Change from baseline to 3 months, 6 months, 1 year |
| Co-efficient of variation of angular velocity of ankle during three phases of gait cycle, heel-strike, push-off, swing averaged over a walk of at least 50 steps | ratio of standard deviation to mean converted to percent. | Change from baseline to 3 months, 6 months, 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Motivation | Starkstein Apathy Scale (0-42, higher worse) | Change from baseline to 3 months, 6 months, 1 year |
| Apathy | Motivation Inventory (0-68, higher worse) |
Not provided
Inclusion Criteria:
Technology readiness will be determined by the following criteria:
To screen participants for their capacity to use the Heel2Toe sensor, participants meeting the technology readiness criteria will be instructed to send a smartphone video of themselves doing a modified Timed-up-an-Go test65 in which the person, stands up from a chair, walks minimum of 10 meters (original TUG is 3 m.), turns, walks back to the chair, and sits down (long-TUG).
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Division of Clinical Epidemiology | Montreal | Quebec | H3A 1A1 | Canada | ||
| Research Institute of the McGill University Health Center, CORE, 5252 de Maisonneuve |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
| UNKNOWN |
Individual, blocked, stepped-wedge
Not provided
Not provided
Everyone eventually gets the intervention, it is the order that is randomized. The outcome is gait quality measured directly from the sensor and is not affected by observers.
Not provided
| Change from baseline to 3 months, 6 months, 1 year |
| Walking behaviour | Daily step count | Change from baseline to 3 months, 6 months, 1 year |
| Health-related quality of life (HRQL) | EQ-5D-5L (0-1; higher is better) | Change from baseline to 3 months, 6 months, 1 year |
| Health-related quality of life (HRQL)better) | Preference-based Parkinson Index (0-100; higher is better) | Change from baseline to 3 months, 6 months, 1 year |
| Self-reported Cognitive Ability | Communicating Cognitive Concerns (C3Q: 0-36, higher is better) | Change from baseline to 3 months, 6 months, 1 year |
| Cognitive Performance Test | Symbol Digit Modality Test (errors in 90 seconds) | Change from baseline to 3 months, 6 months, 1 year |
| Montreal |
| Quebec |
| H4A 3S5 |
| Canada |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |